Ado-trastuzumab emtansine and Insulin aspart protamine and insulin aspart Subcutaneous
Determining the interaction of Ado-trastuzumab emtansine and Insulin aspart protamine and insulin aspart Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Ado-trastuzumab emtansine-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Ado-trastuzumab emtansine-Insulin Aspart Protamine Injection
- Ado-trastuzumab emtansine-Insulin aspart, recombinant Subcutaneous
- Ado-trastuzumab emtansine-Insulin degludec
- Ado-trastuzumab emtansine-Insulin Degludec (U-100) Prefilled Pens
- Insulin aspart protamine and insulin aspart Subcutaneous-Ado-trastuzumab emtansine Intravenous
- Insulin aspart protamine and insulin aspart Subcutaneous-Adox Pak 2/100
- Insulin aspart protamine and insulin aspart Subcutaneous-Adoxa
- Insulin aspart protamine and insulin aspart Subcutaneous-Adoxa CK
- Insulin aspart protamine and insulin aspart Subcutaneous-Adoxa Pak
- Insulin aspart protamine and insulin aspart Subcutaneous-Adoxa Pak 1/100